Backtracking Leukemia-Typical Somatic Mutations in Cord Blood
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission
- Status
- RECRUITING
- Phase
- PHASE1
ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of GDX012 in Patients With MRD Positive AML
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- NA
Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm
- Status
- COMPLETED
- Phase
- PHASE2
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
- Status
- RECRUITING
- Phase
- NA
Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Cardioprotection in AML
- Status
- RECRUITING
- Phase
- PHASE2
Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
- Status
- RECRUITING
- Phase
- PHASE1
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
- Status
- RECRUITING
- Phase
- PHASE1
2157GCCC:Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Dx AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Outcome of Patients With CBF and/or NPM1-mutated AML in First Molecular Relapse.
- Status
- UNKNOWN
- Phase
- N/A
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1